Atlas Trials

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Clinical trial NCT00338130 · COMPLETED

Trial details

NCT number
NCT00338130
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2006-07-01
Primary completion
2007-09-01
Enrollment
239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.